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The bloodstream form of the human pathogen Trypanosoma
brucei expresses oligomannose, paucimannose, and complex
N-linked glycans, including some exceptionally large poly-N-
acetyllactosamine-containing structures. Despite the presence
of complex N-glycans in this organism, no homologues of the
canonical N-acetylglucosaminyltransferase I or II genes can be
found in theT. brucei genome. These genes encode the activities
that initiate the elaboration of the Man1–3 and Man1–6
arms, respectively, of the conserved trimannosyl-N-acetylchito-
biosyl core of N-linked glycans. Previously, we identified a
highly divergent T. brucei N-acetylglucosaminyltransferase I
(TbGnTI) among a set of putative T. brucei glycosyltransferase
genes belonging to the 3-glycosyltransferase superfamily
(Damerow,M., Rodrigues, J. A., Wu, D., Güther, M. L., Mehlert,
A., and Ferguson, M. A. (2014) J. Biol. Chem. 289, 9328–9339).
Here, we demonstrate that TbGT15, another member of the
same 3-glycosyltransferase family, encodes an equally diver-
gent N-acetylglucosaminyltransferase II (TbGnTII) activity. In
contrast to multicellular organisms, where GnTII activity is
essential,TbGnTII nullmutants ofT. brucei grow in culture and
are still infectious to animals. Characterization of the large poly-
N-acetyllactosamine containing N-glycans of the TbGnTII null
mutants by methylation linkage analysis suggests that, in wild-
type parasites, the Man1–6 arm of the conserved trimannosyl
core may carry predominantly linear poly-N-acetyllactosamine
chains, whereas the Man1–3 arm may carry predominantly
branched poly-N-acetyllactosamine chains. These results pro-
vide further detail on the structure and biosynthesis of com-
plex N-glycans in an important human pathogen and provide
a second example of the adaptation by trypanosomes of
3-glycosyltransferase family members to catalyze 1–2 gly-
cosidic linkages.
The African trypanosomes are protozoan parasites that
cause human African sleeping sickness and Nagana in cattle.
The parasite undergoes a complex life cycle between the mam-
malian host and the blood-feeding tsetse fly vector (Glossina
sp.). Throughout this life cycle, Trypanosoma brucei is coated
by glycosylphosphatidylinositol (GPI)8-anchored proteins. The
bloodstream form of the parasite in the mammalian host is
covered by a coat of 5 106 variant surface glycoprotein (VSGs)
homodimers and evades the immune system by replacing one
VSG coat by another, in a process known as antigenic variation
(1–4). The VSG GPI anchors contain side chains of 0–6 Gal
residues, depending on the VSG variant (5–7) and between 1
and 3 N-linked glycans. The latter can be of oligomannose,
paucimannose, or complex types (6, 8, 9). T. brucei expresses
numerous other GPI-anchored and transmembrane glycopro-
teins at the cell surface, in the flagellar pocket, and in the intra-
cellular endosomal/lysosomal system, some of which are life
cycle stage-specific or display life cycle stage-specific glycosyl-
ation differences. For example, the transmembrane invariant
surface glycoproteins ISG65 and ISG75 (10) and the GPI-an-
chored flagellar pocket ESAG6/ESAG7 heterodimeric transfer-
rin receptors (11–13) are specific to the bloodstream life cycle
stage, whereas the major lysosomal glycoprotein p67 is com-
mon to bloodstream and procyclic stages but contains complex
N-glycans only in the bloodstream stage (14). This control of
stage-specific glycosylation resides primarily at the level of oli-
gosaccharyltransferase expression (15). Thus, in the blood-
stream form of T. brucei both the TbSTT3A and TbSTT3B
genes are expressed, and it appears that TbSTT3A co-transla-
tionally scans for glycosylation sequons in relatively acidic local
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environments, transferring exclusively Man5GlcNAc2 that is
destined to be processed to paucimannose or complex N-gly-
cans, whereas TbSTT3B post-translationally modifies any
remaining sequons with Man9GlcNAc2 that is destined to be
processed no further than Man5GlcNAc2 in the conventional
oligomannose series. Conversion from the oligomannose series
to the complex series by the conventional mammalian-type
route cannot occur because the parasite lacks a Golgi -man-
nosidase II gene (16). In the procyclic form of T. brucei, the
expression of TbSTT3A is repressed at both the mRNA level
(15) and protein level (17), favoring the transfer of Man9
GlcNAc2 and the predominant expression of the conventional
Man5GlcNAc2-Man9GlcNAc2 oligomannose series (18).
The survival strategies of protozoan parasites frequently
involve the participation of glycoconjugates.T. brucei expresses
many glycoproteins containing Gal and GlcNAc, including gly-
coproteins with novel bloodstream form-specific giant poly-N-
acetyllactosamine (poly-LacNAc) containing N-linked glycans
(19). The creation of UDP-glucose 4-epimerase (TbGalE) con-
ditional null mutants showed that this gene, and hence UDP-
Gal, is essential for the survival of the parasite in both the blood-
stream and procyclic form life stages (20–22). Similarly, the
creation of UDP-GlcNAc pyrophosphorylase (TbUAP) and
glucosamine 6-phosphateN-acetyltransferase (TbGNA) condi-
tional null mutants has shown that UDP-GlcNAc is essential
for bloodstream form of T. brucei (23, 24). From these experi-
ments, it is possible to conclude that one or more of the UDP-
Gal- and UDP-GlcNAc-dependent glycosylation pathways are
essential to the parasite. This has provided the impetus to
identify and characterize the UDP-Gal- and UDP-GlcNAc-
dependent glycosyltransferase (GT) genes in the parasite. We
previously reported a family of 21 genes with predicted amino
acid sequences consistent with being UDP-sugar-dependent
GTs. All 21 putative T. brucei GT amino acid sequences are
similar to those of the mammalian 3GT family (25). The
mammalian 3GT family includes Gal, Glc, glucuronic acid,
GlcNAc, and GalNAc -3 transferases, and its members con-
tain N-terminal transmembrane domains followed by three
conserved motifs as follows: (I/L)RXXWG, (F/Y)(V/L/M)XXX-
DXD, and (E/D)D(A/V)(Y/F)XGX(C/S). The comparable
motifs in the T. brucei genes are slightly different, WG,
Y(I,V,F)XKXDDD, and ED(A/V/I/L/M)(M/L)X(G/A), but nev-
ertheless, they identify the parasite genes as belonging to the
3GT superfamily (26). One of these genes (TbGT8) encodes a
1–3 GlcNAc transferase and another (TbGT3) a 1–3 Gal
transferase thatmodifies the complexGPI anchor side chains of
the procyclins (the major surface glycoproteins of the procyclic
life cycle stage) (26–28). However, we recently reported that
another gene (TbGT11) encodes a 1–2 GlcNAc transferase
that performs a similar role to members of the N-acetylgluco-
saminyltransferase I family, in that it transfers GlcNAc in 1–2
linkage to the 3-arm of Man1–6(Man1–3)Man1-
4GlcNAc1–4GlcNAc (1).
Here, we report that another T. brucei 3GT superfamily
gene member (TbGT15) encodes another 1–2 GlcNAc trans-
ferase that was already localized to the Golgi apparatus (29, 30).
It performs a similar role tomembers of theN-acetylglucosami-
nyltransferase II family in that it transfersGlcNAc in1–2 link-
age to the 6-arm of Man1–6(Man1–3)Man1–4GlcNAc1-
4GlcNAc, emphasizing the highly divergent nature of the
trypanosome genes involved in structurally conserved aspects
of complex N-glycan biosynthesis.
Experimental Procedures
Cultivation of Trypanosomes—T. brucei brucei strain 427
bloodstream form parasites, expressing VSG variant 221 and
transformed to stably express T7 polymerase and the tetracy-
cline repressor protein under G418 antibiotic selection (31),
were used in this study. This genetic background will be
referred to as wild-type (WT). Cells were cultivated in HMI-9
medium containing 2.5 g/ml G418 at 37 °C in a 5% CO2 incu-
bator as described previously (31).
DNA and RNA Isolation and Manipulation—Plasmid DNA
was purified from Escherichia coli (-select chemically compe-
tent cells, Bioline, London, UK) using Qiagen Miniprep or
Maxiprep kits, as appropriate.Gel extraction and reaction clean
upwas performed usingQIAquick kits (Qiagen). Customoligo-
nucleotides were obtained from Eurofins MWGOperon or the
Dundee University oligonucleotide facility. T. brucei genomic
DNAwas isolated from2 108 bloodstream form cells using
DNAzol (Helena Biosciences, UK) by using standard methods.
T. bruceimRNAwas extracted from 1 107 cells using RNeasy
RNA extraction kit (Qiagen).
Generation of Gene Replacement Constructs—The 517-bp 5
and 454-bp 3 UTR sequences next to the Tb427.7.300 ORF
were PCR-amplified from genomic DNA using Pfu DNA poly-
merase with primers 5-cgttGTCGACagtatccgcaaaatgcgact-3
and 5-gtttaaacttacggaccgtcaagctttatttttctttccctacgcac-3 and
5-gacggtccgtaagtttaaacggatccaaagcggaataaaaataaatc-3 and
5-ataagtaaGCGGCCGCagatgtcgcgcaagaaaaac-3 as forward
and reverse primers, respectively. The two PCR products were
used together in a further PCR to yield a product containing the
5-UTR linked to the 3-UTR by a short HindIII (underlined),
PmeI (italics), and BamHI (underlined) cloning site and NotI
and SalI restriction sites at each end (capital letters). The prod-
uct was cloned between the NotI and SalI sites of the pGEM-
5Zf() vector (Promega).
The hygromycin phosphotransferase (HYG) and puromycin
acetyltransferase (PAC) drug-resistance genes were then intro-
duced into the targeting vector via the HindIII and BamHI
cloning sites. For re-expression of Tb427.7.300, the ORF was
PCR-amplified from genomic DNA with the primer pair 5-
agaaagcttatggtgtggagtgggcataaa-3 and 5-ttcagatcttcatgtgcac-
gaggcgtgcca-3 and cloned into pLEW100-Phleo (31).
For overexpression of full-length TbGT15 with a C-terminal
3 HA epitope tag, a plasmid was generated based on the
trypanosome expression vector pLEW82 (31). TbGT15 ORF
was amplified from T. brucei genomic DNA and the primers
5-gactaagcttatggtgtggagtgggcataaatac-3 and 5-gactttaattaat-
gcgtaatcagggacgtcataaggatatgcgtaatcagggacgtcataaggatacgctc-
ccgcTGTGCACGAGGCGTGCCATC-3 containing a HindIII
and PacI restriction site (underlined), respectively. The
sequence encoding for two HA tags (italics) followed by a
sequence encoding an Ala-Gly-Ala linker was attached as a
5-overhang of the reverse primer. The PCR product was sub-
cloned into pLEW82-GPIdeAc-HA (32) via HindIII and PacI
T. brucei N-Acetylglucosaminyltransferase II
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restriction sites under replacement of the GPIdeAc insert, but
retention of the sequence encoding for one HA tag, resulting in
the plasmid pLEW82-TbGT15-HA3. The identity of all con-
structs was confirmed by sequencing.
Transformation of Bloodstream Form T. brucei—Constructs
for gene replacement and ectopic expression were purified,
digested with NotI to linearize, precipitated, washed with 70%
ethanol, and re-dissolved in sterile water. The linearized DNA
was electroporated intoT. brucei bloodstream formcells (strain
427, variant 221) that were stably transformed to express T7
RNA polymerase and the tetracycline repressor protein under
G418 selection. Cell culture and transformation were carried
out as described previously (31–33).
Southern Blotting—Aliquots of genomic DNA isolated from
100 ml of bloodstream form T. brucei cultures (2 108 cells)
were digested with EcoRI, resolved on a 0.8% agarose gel and
transferred onto a Hybond-N positively charged membrane
(GEHealthcare,UK).Highly sensitiveDNAprobes labeledwith
digoxigenin-dUTP were generated using the PCR digoxigenin
probe synthesis kit (Roche Applied Science) according to the
manufacturer’s recommendations and hybridized overnight at
42 °C. Detection was performed using alkaline phosphatase-
conjugated anti-digoxigenin Fab fragments and the chemilumi-
nescent substrate CSPD (Roche Applied Science).
Mouse Infectivity Studies—Wild-type and TbGT15 null
mutant bloodstream form trypanosomes were grown in
HMI-9T media, washed in media without antibiotics, and
resuspended at 5 106 cells/ml. Groups of five female BALB/c
mice were used for each cell line, and 0.1 ml of the suspension
above was injected intraperitoneally per animal. Infections
were assessed 3 days post-infection by tail bleeding and cell
counting using a Neubauer chamber in a phase contrast
microscope.
Semi-quantitative RT-PCR—To assess the amount of
Tb427.7.300 mRNA in the TbGT15 conditional null mutant
cells grown under permissive and non-permissive conditions,
RT-PCRs were performed using AccessQuick RT-PCR System
(Promega) according to the manufacturer’s recommendations.
ATbGT15 350-bp fragment was amplified with the primer pair
5-cacattgtcgcgggatgtgagtgag-3 and 5-ccatcccaagtacccgcggt-
aaaatggg-3. As a control to ensure similar RNA levels in both
samples, primers 5-aatggatgcggaccttcagcacccac-3 and 5-tag-
aaccgtgagcgcggtgccatac-3 amplifying a 448-bp product of
dolichol phosphate mannose synthase (Tb10.70.2610) were
used.
Small Scale sVSG Isolation—Soluble form VSG (sVSG) was
isolated from 100 ml of cultures containing 2  108 blood-
stream form T. brucei by amodification of the method of Cross
and co-workers (34, 35) as described previously (36). Briefly,
cells were chilled on ice, centrifuged at 2500 g for 10min, and
washed in an isotonic buffer. The pellet was resuspended in 300
l of lysis buffer (10 mM NaH2PO4 buffer, pH 8.0, containing
0.1mM tosyllysine chloromethyl ketone hydrochloride (TLCK),
1 g/ml leupeptin, and 1 g/ml aprotinin) and incubated for 5
min at 37 °C. The sample was centrifuged at 14,000  g for 5
min, and the supernatant was applied to a 200-l DE52 anion
exchange column pre-equilibrated in 10mM sodiumphosphate
buffer, pH 8.0. Elution was performed with 0.8 ml of 10 mM
sodium phosphate buffer, pH 8.0, and the eluate was concen-
trated and diafiltered with water on a YM-10 spin concentrator
(Microcon). The final sample of 50–100 g of sVSG221 was
recovered in a volume of 100 l of water.
ES-MS Analysis of Intact sVSG—50 g of aliquots of sVSG
preparations were diluted to0.05 g/l in 50%methanol, 1%
formic acid and analyzed by positive ion ES-MS on a Q-Tof
6520 instrument (Agilent). Data were collected, averaged, and
processed using the maximum entropy algorithm of the Mass-
Hunter software (Agilent).
Lectin Blotting of Cell Extracts—To analyze N-glycosylation
of T. brucei bloodstream form cells, 2  108 cells were first
depleted of VSG by hypotonic lysis (34, 35). For Western blot
analysis, residual cell ghosts were solubilized in SDS sample
buffer containing 8 M urea, boiled with DTT, separated by SDS-
PAGE (1  107 cell eq/lane) on NuPAGE bis-Tris 4–12%
gradient acrylamide gels (Invitrogen) and transferred to a nitro-
cellulose membrane (Invitrogen). Ponceau S staining con-
firmed equal loading and transfer. Glycoproteins were probed
with 1.7 g/ml biotin-conjugated ricin (RCA-120, Vector Lab-
oratories, UK) in PBS before or after pre-incubation with 10
mg/ml D-galactose and 10 mg/ml -lactose to confirm specific
ricin binding. Detection was performed using IRDye 680LT-
conjugated streptavidin and the LI-COR Odyssey infrared
imaging system (LICOR Biosciences, Lincoln, NE).
Structural Analysis of the Large N-Glycan Fraction—Blood-
stream form cells of wild-type and TbGT15 null mutant cells
were isolated from infected rats and processed as described
(19). Briefly, VSG-depleted cell ghosts of 1 1011 cell eq were
solubilized with SDS/urea buffer followed by lectin affinity
chromatography using ricin-agarose (RCA-120, Vector Labo-
ratories).N-Glycans from the ricin-binding glycoproteins were
released with peptide:N-glycosidase F (Flavobacterium menin-
gosepticum, Roche Applied Science) and applied to a Bio-Gel
P-4 gel filtration column. Aliquots of eluted fractions were sub-
jected to methanolysis, trimethylsilylation, and GC-MS mono-
saccharide composition analysis (37). Fractions that eluted in
the void volume of the column (the total poly-LacNAc fraction,
rich in Gal and GlcNAc) were pooled and used for methylation
linkage analysis. After permethylation, acid hydrolysis, NaBD4
reduction, and acetylation, the resulting partially methylated
alditol acetates (PMAAs) were analyzed by GC-MS (Agilent) as
described previously (38). Authentic glycans of Gal1–4Glc
NAc1–2Man1–6(Gal1–4GlcNAc1–2Man1–3)Man1-
4GlcNAc1–4GlcNAc, lacto-N-neohexaose Gal1–4Glc
NAc1–6(Gal1–4GlcNAc1–3)Gal1–4Glc, lacto-neote-
traose Gal1–4Glcl1–3Gal1–4GlcNAc, and Gal1–6Gal
(Dextra Laboratories, UK) were subjected to methylation link-
age analysis alongside the experimental samples. Using the
PMAA derivative derived from non-reducing terminal galac-
tose residues, common to all of these structures (i.e. 1,5-di-O-
acetyl-2,3,4,6-tetra-O-methyl-1-[2H]galactitol), we were able
to inter-relate these data and determine the total ion current
molar relative response factors for the PMAAs derived from
terminal-Gal, 3-O-substituted Gal, 6-O-substituted Gal 3,6-di-
O-substituted Gal, 2-O-substituted Man, 3,6-di-O-substituted
Man, and 4-O-substituted GlcNAc (1.59, 0.99, 0.27, 0.90, 1.20,
1.00, and 0.23, respectively). These molar relative response fac-
T. brucei N-Acetylglucosaminyltransferase II
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tor values were used to correct the peak integrations of sample
PMAA total ion current chromatograms and thus provide
molar ratios of the PMAAs in the methylation linkage analyses
of the wild-type and TbGT15 null glycan samples.
GnTII in Vitro Activity Assay—TbGT15 fused to a C-termi-
nal triple HA tag was overexpressed in T. brucei bloodstream
form cells. 1 109 cells were lysed on ice in 25mMTris, pH 7.5,
100 mM NaCl, 1% Triton X-100 containing a mixture of prote-
ase inhibitors (CompleteMini, Roche Applied Science), and 0.1
mMTLCK. Expressionwas confirmed by SDS-PAGEandWest-
ern blotting. Briefly, 5  106 cell eq/lane were separated on
NuPAGE bis-Tris 4–12% gradient acrylamide gels (Invitrogen)
and transferred to nitrocellulose membrane (Invitrogen). Pon-
ceau S staining confirmed equal loading and transfer. Detection
was performed using 0.5 g/ml rabbit anti-HA antibody (QED
Bioscience Inc., San Diego) and IRDye 680LT-conjugated don-
key anti-rabbit IgG and the LI-COR Odyssey infrared imaging
system (LICOR Biosciences). For the in vitro activity assay,
TbGT15-HA3 was immunoprecipitated using anti-HA mag-
netic beads (Pierce) and incubated with 1 Ci of UDP-
[3H]GlcNAc (specific activity of 20–40 Ci/mmol, PerkinElmer
Life Sciences), 1 mM cold UDP-GlcNAc (Sigma), and 5 g of
Man1–6(Man1–3)Man1–4GlcNAc1–4GlcNAc or 25
g of 1–3,1–6-mannotriose (both Dextra Laboratories,
Reading, UK) in 50 mM Tris, pH 7.5, 10 mM MgCl2, 10 mM
MnCl2 in a total volume of 50 l. After overnight incubation
under vigorous shaking at room temperature, samples were
desalted via a mixed-bed ion exchange column of 100 l of
Chelex-100 (Na) over 100l of AG50X12 (H) over 200l of
AG3X4 (OH) over 100 l of QAE-Sephadex 25 (OH), all
from Bio-Rad, UK, except QAE-Sephadex (Sigma). Finally, gly-
cans were freeze-dried and re-dissolved in 20% 1-propanol, and
aliquots were spotted onto silica HPTLC plates (SI-60 HPTLC,
Millipore) thatwere run twice in 1-propanol/acetone/H2O (9:6:
4). For product analysis, samples were treated with 128 units of
1–2,3 mannosidase from Xanthomonas manihotis (New Eng-
land Biolabs) or 0.2 units of -N-acetylglucosaminidase from
Canavalia ensiformis (Sigma) before TLC analysis. Plates were
then dried, sprayed with EN3HANCE autofluorography
enhancer (EN3HANCE, PerkinElmer Life Sciences), and
exposed on x-ray film at 80 °C for 1–2 days.
For mass spectrometric analysis of the reaction product,
the assay was performed using 5 mM non-radioactive UDP-
GlcNAc. Samples were analyzed by LC-MS using a HILIC col-
umn (Tosoh TSKgel Amide column, 1 mm  10 cm) and a
gradient of 80 to 5% acetonitrile in 0.1% formic acid at a flow
rate of 50l/min using aTSQQuantiva triple-quadrupolemass
spectrometer (Thermo Fisher Scientific). For methylation link-
age analysis of the product, glycans were converted to constit-
uent monosaccharides in the form of partially methylated aldi-
tol acetates and analyzed by GC-MS as described above.
Scanning Electron Microscopy—To analyze bloodstream
form cells by scanning electron microscopy, cells were fixed in
HMI-9 medium with 2.5% glutaraldehyde. They were further
processed and examined in a Philips XL30 ESEM operating at
an accelerating voltage of 15 kV by the Centre for High Resolu-
tion Imaging and Processing (CHIPS) at the University of
Dundee.
Results
Analysis of the TbGT15 Gene Product—We previously char-
acterized the biological function of threemembers of a family of
putative UDP-sugar-dependent GTs (1, 26, 27). In this study,
Tb927.7.300 was selected for functional analysis. The gene
encodes for a 367-amino acid protein with a theoretical molec-
ular mass of 43.1 kDa. Stable isotope labeling with amino acids
in cell culture-based quantitative proteomic data demonstrated
that the protein expression level is 15 times higher in blood-
stream form parasites compared with procyclic form parasites
(40).
The T. brucei strain that was used in this study (Lister strain
427) differs from the one that was used for the reference
genome sequencing project (TREU927). However, an align-
ment of Tb927.7.300 and its homologueTb427.7.300 revealed a
very high similarity with only three single nucleotide polymor-
phisms, none of them resulting in amino acid changes. The
strain 427 gene and protein product will be referred to here as
TbGT15 and TbGT15, respectively.
The protein sequence contains several hallmarks of Golgi
apparatus glycosyltransferases. First, a membrane protein
topology prediction program based on a hiddenMarkov model
(41) designates TbGT15 as a type II transmembrane protein. In
addition, the sequence contains aDXDmotif, which is generally
involved in catalytic activity of known GTs (42) as well as a
dibasicmotif, which functions as an endoplasmic reticulumexit
signal (43). Indeed, a subcellular Golgi localization of TbGT15
was confirmed previously (29, 30).
Creation of BloodstreamFormTbGT15Null andConditional
Null Mutants—As TbGT15 is predominantly expressed in
bloodstream form parasites (40), we decided to investigate the
protein function by creating null and conditional null mutants
in this life cycle stage. BLAST search of the T. brucei genome
suggested that TbGT15 is present as a single copy per haploid
genome. Both alleleswere sequentially replaced by homologous
recombination using PAC andHYG drug resistance cassettes as
summarized in Fig. 1A. After selection on the respective
antibiotics, the generation of a TbGT15 null mutant (TbGT15::
PAC/TbGT15::HYG) was confirmed by Southern blot using
probes for the TbGT15ORF and 3UTR (Fig. 1B). To allow for
a tetracycline-inducible re-expression of the gene, an ectopic
copy ofTbGT15was introduced into the rRNA locus of the null
mutant background using the pLEW100 vector (31). Clones
were selected on phleomycin, and the creation of this condi-
tional null mutant (TbGT15Ti/TbGT15::PAC/TbGT15::
HYG) was confirmed by RT-PCR (Fig. 1C).
Nomorphological differences between theWT and TbGT15
null mutant parasites could be ascertained by light microscopy
or by scanning electron microscopy (Fig. 2A). Compared with
WT cells, the TbGT15 null mutant parasites exhibited slightly
slower growth kinetics in vitro, and thismild growth phenotype
was partially reversed in TbGT15 conditional null cells grown
under permissive conditions (Fig. 2B). In addition, no differ-
ence in its ability to infect mice could be detected for the
TbGT15 null mutant (Fig. 2C). From this we can conclude that
TbGT15 is a non-essential gene in T. brucei bloodstream form
cells.
T. brucei N-Acetylglucosaminyltransferase II
JUNE 24, 2016•VOLUME 291•NUMBER 26 JOURNAL OF BIOLOGICAL CHEMISTRY 13837
 at U
N
IV
ERSITY
 O
F D
U
N
D
EE on June 28, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Characterization of VSG fromWTand TbGT15NullMutant
Parasites—VSG221 fromWT cells is heterogeneously glycosy-
lated, containing a highly galactosylated GPI anchor (5), one
oligomannose N-glycan at Asn-428 (Man5-9GlcNAc2), as well
as small biantennary structures ranging fromMan3GlcNAc2 to
Gal2GlcNAc2Man3GlcNAc2 atAsn-296 (8, 16). VSGcanbe iso-
lated in its sVSG form by hypotonic lysis, which results in its
release by of endogenous GPI-specific phospholipase C (44).
To assess differences in the glycosylation phenotype, intact
sVSGs fromWT and TbGT15 null mutant parasites were ana-
lyzed by ES-MS in positive-ion mode (Fig. 3). VSG molecules
containing a total of four or five GlcNAc residues were present
at similar levels in both genotypes, but glycoforms with six
GlcNAc residues were completely absent in the TbGT15 null
mutant (see arrows in Fig. 3B andTable 1). Bearing inmind that
four GlcNAc residues are necessary for the composition of the
two N-glycan N-acetylchitobiose core structures, the lack of
VSG glycoforms containing six GlcNAc residues strongly indi-
FIGURE1.Generationof abloodstreamformTbGT15null and conditional
nullmutant.A, gene replacement strategy to create TbGT15nullmutant cells
and subsequent insertion of tetracycline-inducible ectopic copy, in brackets,
to create a conditional null mutant. B, Southern blot of genomic DNA
digested with EcoRI fromWT (lanes 1, 3, and 5) and TbGT15 null mutant cells
(lanes 2, 4, and 6). The blot was probed with a TbGT15 ORF probe (left panel)
and a TbGT15 3UTRprobe (middle panel) and shows the replacement of both
alleles with drug resistance cassettes. Equal loadingwas verified by ethidium
bromide staining (right panel). C, ethidium bromide-stained agarose gel of
reverse transcription-PCR products from RNA extracted fromWT cell, TbGT15
null, and conditional null mutants. TbGT15mRNAwas detected inWT (lane 1)
and TbGT15 conditional null mutant cells grown under permissive (plus tet-
racycline) conditions (lane 4), although no mRNA was found in TbGT15 null
mutants (lane 2) and TbGT15 conditional null mutants grown under non-per-
missive conditions (lane 5). To showequal RNA input, a control usingdolichol-
phosphate mannose synthase (DPMS) primers was performed with TbGT15
null mutants (lane 3) and TbGT15 conditional null mutants grown under non-
permissive conditions (lane 6).
FIGURE 2.Absence of TbGT15does not affect bloodstream form trypano-
somemorphology and growth. A, scanning electronmicrographs of repre-
sentativeWT (left panel) and TbGT15nullmutant cells (right panel); scale bar, 2
m. B, growth curves for bloodstream form T. brucei wild-type cells (WT;
gray diamonds), TbGT15 null mutant cells (TbGT15DKO; black squares), and
TbGT15 conditional null mutant cells grown under permissive conditions
(TbGT15cDKO; gray triangles). Cell counts were taken daily in triplicate; error
bars indicate one S.D. of themean. C, infectivity of wild-type and TbGT15 null
mutant bloodstream fromparasites tomice. Mice were infectedwith 5 105
cells ofWT (black) or TbGT15 null mutants (gray), and the number of parasites
per ml blood was counted 3 days post-infection. No difference in infectivity
was observed.
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cates a deficiency in biantennary complex N-glycans at Asn-
296. From this we can conclude that themutant cells are unable
to express complex N-glycans and that TbGT15 is involved in
their biosynthesis.
In Vitro Functional Activity Assay—To verify that TbGT15
encodes a glycosyltransferase that is directly involved in the
biosynthesis of hybrid or complex N-glycans, we performed an
in vitro assay for enzymatic activity as described previously (1).
Briefly, full-length TbGT15 fused to a C-terminal 3 HA
epitope tag was expressed in T. brucei bloodstream form cells
and immunoprecipitated using anti-HA magnetic beads. The
protein was incubated with Man1–6(Man1–3)Man1-
4GlcNAc1–4GlcNAc as acceptor substrate and tritium-
labeled UDP-[3H]GlcNAc as donor substrate. Following
desalting and removal of excess UDP-[3H]GlcNAc donor by
mixed-bed ion exchange, aliquots were separated by thin
layer chromatography (TLC) and analyzed by fluorography.
Although a control immunoprecipitation with lysate fromWT
cells did not result in any [3H]GlcNAc incorporation (Fig. 4A,
lane 2), the sample containing TbGT15-HA3 showed a strong
signal of tritium-labeled reaction product (Fig. 4A, lane 1). This
demonstrates that TbGT15 is able to transfer GlcNAc to bian-
tennaryMan1–6(Man1–3)Man1–4GlcNAc1–4GlcNAc
core structures. It is noteworthy that the shortened substrate
Man1–6(Man1–3)Man lacking the chitobiose core was not
used as an UDP-GlcNAc acceptor by TbG15 (Fig. 4A, lane 3).
To reveal whether GlcNAc is transferred to theMan1–3 or
Man1–6 arm of Man1–6(Man1–3)Man1–4GlcNAc1-
4GlcNAc, the reaction product was treated with 1–2,3-man-
nosidase. As seen in the subsequent TLC/autofluorography
analysis, mannosidase treatment caused an increased mobility
of the reaction product (compare Rf values in Fig. 4B). This
suggests that the 3-Man arm was not modified by TbGT15,
leaving it susceptible to exoglycosidase cleavage, and allows us
to conclude that the transferred GlcNAc residue is attached
to the 6-Man arm of the Man1–6(Man1–3)Man1-
4GlcNAc1–4GlcNAc core structure. The anomeric configu-
ration of the newly formed linkage was determined by -N-
acetylglucosaminidase digestion of the reaction product. In
the following TLC/autofluorography analysis, the band of trit-
ium-labeled GlcNAcMan3GlcNAc2 disappeared, although the
amount of free [3H]GlcNAc increased, demonstrating a -con-
figuration (Fig. 4C).
For further characterization of the reaction product, the
assay was performed using non-radioactive UDP-GlcNAc.
First, HILIC-MS was performed to identify the HexNAc3Hex3
reaction product (Fig. 5, A and B). A subsequent methylation
linkage analysis on the reaction sample by GC-MS demon-
strated the presence of 1,2,5-tri-O-acetyl-(1-deutero)-3,4,6-tri-
O-methyl-mannitol, originating from 2-O-substitued man-
nose, which reveals that TbGT15 transfers GlcNAc in a 1–2
linkage to one of the non-reducing terminal mannose residues
of the trimannosyl core (Fig. 5, C and D).
Taken together, these data show that TbGT15 is the glyco-
syltransferase responsible for the transfer of 1–2-linked
GlcNAc to the 1–6-linked -D-mannopyranosyl residue of
Man1–6(Man1–3)Man1–4GlcNAc1–4GlcNAc and can
therefore be termed anN-acetylglucosaminyltransferase type II
or TbGnTII.
N-Glycosylation Phenotype of Bloodstream Form TbGT15
Mutant Parasites—To investigate the effect of TbGT15 on the
glycosylation of other proteins than VSG, total glycoproteins
were extracted with SDS/urea from VSG-depleted trypano-
some ghosts and analyzed by lectin blotting. As reported previ-
ously for WT T. brucei, ricin (RCA-120), a lectin that predom-
inantly binds to non-reducing terminal -galactose residues,
showed strong binding to a series of glycoproteins running
between 60 and 150 kDa (Fig. 6, 1st lane). Ricin binding to
glycoproteins extracted from the TbGT15 null mutants was
slightly reduced, and the apparent molecular mass of all signals
was marginally smaller compared with WT signals (Fig. 6, 2nd
lane). Albeit subtle, these changes in blotting pattern suggest an
alteration in the synthesis of the large poly-LacNAc-containing
glycans of the high molecular weight invariant glycoproteins
(19).
To draw structural conclusions, we decided to analyze the
ricin-binding glycoprotein fraction by methylation linkage as
described previously (19). Briefly,WTandTbGT15nullmutant
cells were isolated, depleted of VSGs, solubilized in SDS/urea,
and glycoproteins were purified by ricin affinity chromatogra-
phy. N-Linked glycans were released by peptide:N-glycosidase
F and further fractionated by Bio-Gel P-4 gel filtration, result-
ing in two main fractions as follows: one containing the rela-
tively small mannose-rich N-glycans, and a Gal/GlcNAc-rich
high molecular mass fraction eluting at the void volume of the
Bio-Gel P-4 column (the total poly-LacNAc fraction). Aliquots
of these fractions were subjected to neutral monosaccharide
composition analysis by GC-MS. The molar ratios of Gal/Man
FIGURE 3. sVSG221glycoformanalysis by ES-MS. Samples of intact sVSGof
WT (A) and TbGT15 null mutant trypanosomes (B) were analyzed by positive-
ion ES-MS, and the deconvolved spectra of the various isobaric glycoforms
were generated (the compositions of these glycoforms are given in Table 1).
Significant differences in the sVSG glycosylation patterns are indicated by
arrows in B.
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in the total poly-LacNAc fraction forWT (19) andTbGT15 null
mutant parasites were found to be similar, 14.5:1 and 12.4:1,
respectively.
Subsequent GC-MSmethylation linkage analysis of the total
poly-LacNAc fraction revealed structural similarities but also
some quantitative differences (Table 2). Thus, both WT and
TbGT15 null total poly-LacNAc glycans contain 2-O-substi-
tuted Man and 3,6-di-O-substituted Man, consistent with a
conventional core structure of R-2Man1–6(R-2Man1–3)
Man1–4GlcNAc1–4GlcNAc in all structures. Furthermore,
both samples contained significant amounts of 4-O-substi-
tuted GlcNAc, indicating the presence of multiple LacNAc
TABLE 1
Isobaric glycoforms of sVSG221 identified by ES-MS
Themolecular masses of different glycoforms of sVSG221 were calculated according to the indicated compositions (the theoretical mass of the assigned VSG composition
is shown in parentheses). The relative abundances of those glycoforms observed in Fig. 3 for sVSG preparations from sVSG ofWT cells and TbGT15 null mutant cells are
indicated by, trace,,, and scores. NA means not applicable.
Mass (in Da) WT/TbGT15
null mutant (theoretical) Proteina GlcN-Ino-cPb EtNP GlcNAc
Man
Gal WT
TbGT15 null
mutant
50,204/50,202 (50,194) 1 1 1 4 16 c Traces
50,241/50,242 (50,235) 1 1 1 5 17 Traces 
50,366/50,364 (50,356) 1 1 1 4 17  
50,405/50,404 (50,397) 1 1 1 5 16 Traces 
50,528/50,526 (50,518) 1 1 1 4 18  
50,568/50,566 (50,559) 1 1 1 5 17  Traces
50,608/NA (50,600) 1 1 1 6 16 Traces 
50,690/50,688 (50,680) 1 1 1 4 19  
50,731/50,728 (50,721) 1 1 1 5 18  
50,770/NA (50,762) 1 1 1 6 17 Traces 
50,852/50,850 (50,842)d 1 1 1 4 20  
50,893/50,891 (50,883) 1 1 1 5 19  
50,933/NA (50,924) 1 1 1 6 18  
51,014/51,012 (51,004) 1 1 1 4 21  
51,055/51,053 (51,045) 1 1 1 5 20  
51,097/NA (51,086) 1 1 1 6 19  
51,177/51,175 (51,166) 1 1 1 4 22  
51,217/51,216 (51,207) 1 1 1 5 21  
51,258/NA (51,248) 1 1 1 6 20  
51,340/51,337 (51,328) 1 1 1 4 23  
51,380/51,377 (51,369) 1 1 1 5 22  Traces
51,421/NA (51,410) 1 1 1 6 21  
51,502/51500 (51,490) 1 1 1 4 24  
51,542/51,539 (51,531) 1 1 1 5 23  Traces
51,583/NA (51,572) 1 1 1 6 22  
51,665/51,662 (51,652) 1 1 1 4 25  Traces
51,706/51,704 (51,693) 1 1 1 5 24  Traces
51,745/NA (51,734) 1 1 1 6 23 Traces 
a Protein mass is based on the amino acid sequences of the VSG221 precursor (accession no. P26332) minus residues 1–27 (signal peptide) and 460–476 (GPI attachment
signal peptide) and allows for four disulfide bonds (mass 46,284 Da).
b Components specific to the GPI anchor and common to all glycoforms: GlcN-Ino-cP, glucosamine-1–6-myo-inositol-1,2 cyclic phosphate; EtNP, ethanolamine
phosphate.
cMaximum entropy deconvolved spectra are only semi-quantitative; an indication of relative abundance of the isobaric glycoforms is given based on peak height.
d The most abundant glycoform of WT sVSG221 is expected to contain a GPI anchor of composition of Man3Gal5 (5), a C-terminal N-linked glycan of Man9GlcNAc2, and
an internal N-linked glycan of Man3GlcNAc2 (8) (i.e. GlcNAc 4, and Man 20).
FIGURE 4. TbGT15 in vitro functional activity assay. Fluorographs of HPTLC plates showing the products of UDP-[3H]GlcNAc and anti-HA-conjugated
magnetic bead immunoprecipitates from T. brucei expressing TbGT15-HA3 incubated with Man1–3(Man1–6)Man1–4GlcNAc1–4GlcNAcor Man1–
6(Man1–3)Man (lane 1 or 3) (A) are shown. As a negative control, anti-HA-conjugated magnetic beads incubated with lysates from cells not expressing
TbGT15-HA3 were used with Man1–3(Man1–6)Man1–4GlcNAc1–4GlcNAc (lane 2). B, [
3H]GlcNAcMan3GlcNAc2 reaction product before (lane 1) and
after (lane 2) treatment with 1–2,3 mannosidase. C, [3H]GlcNAcMan3GlcNAc2 reaction product before (lane 1) and after (lane 2) treatment with
-N-acetylglucosaminidase.
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repeats. However, although the numbers of terminal Gal res-
idues were similar, there was a significant decrease in 6-O-
substituted Gal and 3-O-substituted Gal residues and a con-
comitant increase in 3,6-di-O-substituted-Gal residues in
the TbGT15 null mutant glycans. Because TbGT15 has a
GnTII-type activity that initiates elaboration of the
Man1–6 arm of Man1–6(Man1–3)Man1–4GlcNAc1-
4GlcNAc core, these data are consistent with a model where
linear poly-LacNAc chains predominate on theMan1–6 arm,
and theMan1–3 arm is occupied by both linear and branched
poly-LacNAc units (Fig. 7). The increase in the number of 3,6-
di-O-substituted Gal residues in the TbGT15 mutant glycans
further suggests that deletion of the entire (predominantly lin-
ear) poly-LacNAc chain attached to the Man1–6 arm is, to
some extent, compensated by further elaboration of the (linear
and branched) poly-LacNAc chain attached to the Man1–6
arm.
Discussion
We have cloned the gene that encodes UDP-GlcNAc:1-
6-D-mannoside-1–2-N-acetylglucosaminyltransferase II in T.
brucei, an enzyme that catalyzes an essential step on the route
to complex N-glycans. In human patients with carbohy-
drate-deficient glycoprotein syndrome type II, congenital
deficiency in GnTII activity is associated with severe psy-
chomotor retardation and other multisystemic abnormali-
ties (45, 46). In amousemodel with a homozygous null muta-
tion in the gene encoding GnTII (Mgat2/), 99% of
FIGURE 5. Mass spectrometry analysis of TbGT15 reaction product. HILIC-MS of in vitro assay reaction. A, ion chromatogram showing substrate
HexNAc2Hex3 (eluting at 13.36 min) and reaction product HexNAc3Hex3 (eluting at 13.57 min). The data are adjusted such that 100% relative abundance
corresponds to the normalization level (NL) of 1.34E8 ion counts. B, mass spectrumof HexNAc2Hex3 (substrate, S) andHexNAc3Hex3 (product, P) in protonated
and sodiated form ([SH] 911.51; [SNa] 933.43; [PH] 1114.58; and [PNa] 1136.55). C, GC-MS extracted ion chromatogram of ions (m/z
102, 118, 129, 117, 161, and 190) characteristic for PMAA derivatives obtained after permethylation, acid hydrolysis, sodium borodeuteride reduction, and
peracetylation of the TbGT15 reactionproduct. EIC, extracted ion chromatogram.D, spectrumof the 1,2,5-tri-O-acetyl-(1-deutero)-3,4,6-tri-O-methyl-mannitol
PMAA derived from 2-O-substituted mannose, with characteristic fragment ion assignments.
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newborns die during the first postnatal week (47). These
developmental defects highlight the importance of complex
N-glycans in intercellular communication and signaling in
multicellular organisms.
The significance of complexN-glycans in the unicellular pro-
tozoan T. brucei is less well understood. In the bloodstream
form, the parasite expresses both conventional biantennary
complex N-glycans and unique highly extended and branched
poly-N-acetyllactosamine-containing complex N-glycans (8,
19, 48, 49). However, theT. brucei genome contains no obvious
homologues of the canonical GnTI and GnTII genes that
encode the 1–2GlcNAc transferases usually responsible for
the initiation of complex N-glycans. In a previous study, we
identified and characterized TbGnTI, the enzyme responsible
for the transfer 1–2GlcNAc to theMan1–3 arm ofN-glycan
core structures (1). TbGnTI showed unusual activity in that it
acts on biantennary Man3GlcNAc2 instead of triantennary
Man5GlcNAc2, the preferred acceptor substrate for vertebrate
GnTI activities (50). Remarkably, the TbGnTI gene is highly
divergent from the canonicalGnTI gene family and, despite the
fact that TbGnTI catalyzes a 1–2 linkage, it belongs to the
so-called 3-glycosyltransferase superfamily (1, 26).
In this study, a reverse-genetics approach in T. brucei blood-
stream form cells indicated that the deletion of TbGT15
(another trypanosome 3-glycosyltransferase superfamily
member) is accompanied by the absence of complexN-glycans,
as well as alterations in the biosynthesis of the giant poly-Lac-
NAc-containing glycans. Using a direct enzymatic assay and
comprehensive product analysis, we could show that purified
TbGT15 catalyzes the conversion of Man1–6(Man1–3)
Man1–4GlcNAc1–4GlcNAc to GlcNAc1–2Man1–6
(Man1–3)Man1–4GlcNAc1–4GlcNAc. We have there-
fore renamed TbGT15 to TbGnTII. The conversion of
Man3GlcNAc2 demonstrates that TbGnTII works indepen-
FIGURE 6. Lectin blotting of VSG-depleted glycoproteins. Lysates of
washed WT or TbGT15 null mutant (KO) trypanosome cell ghosts were sub-
jected to SDS-PAGE and transferred to nitrocellulose membrane. The mem-
brane was incubated with ricin (left panel) or, as a binding specificity control,
with ricin that was pre-incubating with 10 mg/ml each of galactose and lac-
tose (middle panel). Equal loading and transfer are demonstrated by Ponceau
S staining (right panel).
FIGURE 7. Proposed scheme for poly-LacNAc-containing N-glycans of
bloodstream form trypanosomes. Thedata presentedhere and in Ref. 1 are
consistentwith themodel shownherewhereby in thewild-typebloodstream
form of T. brucei the majority of large complex N-glycans carry highly
branchedpoly-LacNAc chains on theMan1–3 armandpredominantly linear
poly-LacNAc chains on theMan1–6 arm. In the TbGT15 nullmutant, all elab-
orationof theMan1–6 arm is absent andpartly compensatedby an increase
in the branched poly-LacNAc elaboration of theMan1–3 arm. Note that the
relative positions of branch points shown are arbitrary.
TABLE 2
Quantitative GC-MSmethylation linkage analysis of the total poly-LacNAc fraction
The total poly-LacNAc fraction was permethylated, hydrolyzed, reduced, and acetylated for GC-MS analysis. The resulting PMAA derivatives were identified by retention
time and electron impact mass spectra. Quantification was accomplished by integration of the total ion current using molar relative response factors deduced empirically
from authentic standards, as described under “Experimental Procedures.”
PMAA derivative Origin WTa TbGT15 null mutanta
2,4-Di-O-methyl-1,3,5,6-tetra-O-acetyl-1-[2H]mannitol 3,6-Di-O-substituted Man 1.0 1.0
3,4,6-Tri-O-methyl-1,2,5-tri-O-acetyl-1-[2H]mannitol 2-O-Substituted Man 2.3 2.3
2,3,4,6-Tetra-O-methyl-1,5-di-O-acetyl-1-[2H]galactitol Terminal Gal 4.9 5.0
2,4,6-Tri-O-methyl-1,3,5-tri-O-acetyl-1-[2H]galactitol 3-O-Substituted Gal 2.2 1.7 (down 23%)
2,3,4-Tri-O-methyl-1,5,6-tri-O-acetyl-1-[2H]galactitol 6-O-Substituted Gal 23.4 15.9 (down 32%)
2,4-Di-O-methyl-1,3,5,6-tetra-O-acetyl-1-[2H]galactitol 3,6-Di-O-substituted Gal 3.6 5.0 (up 39%)
3,6-Di-O-methyl-1,4,5-tri-O-acetyl-2-N-methylacetamido-1-[2H]glucosaminitol 4-O-substituted GlcNAc 24.6b 16.6b
aMolar quantities relative to 3,6-di-O-substituted Man (one per glycan) are shown.
b Values for N-acetylglucosamine derivatives are less reliable than for hexoses.
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dently frompriorTbGnTI action,which is in contrast to canon-
ical GnTIIs that only use substrates aftermodification byGnTI,
i.e. Man1–6(GlcNAc1–2Man1–3)Man1–4GlcNAc1-
4GlcNAc (51, 52). This unusual acceptor specificity of the
trypanosome enzyme was already indicated by previous data,
which show the presence of “pseudohybrid” N-glycans in the
absence of TbGnTI (1) and highlights the divergent nature of
TbGnTII. A phylogram based on a multiple sequence align-
ment of TbGT15 and GnTII enzymes of other species is shown
in Fig. 8. The GnTIIs of multicellular organisms belong the
CAZy (carbohydrate-active enzymes)GT family 13 (39) and are
all closely related, with nearly 90% identity between the human
and mouse enzymes. In contrast, TbGnTII is a member of the
CAZy GT31 family (26) and shares only 9% identity with the
human sequence at the amino acid level. Interestingly, although
humanGnTI andGnTII proteins have only a low level of amino
acid sequence homology between them (22%), the TbGnTI and
TbGnTII enzymes share 42% identity. This is consistent with
the closer functional similarity of the trypanosome enzymes,
both of which work on the same acceptor substrate (Man3
GlcNAc2, although only the latter requires theN-acetylchitobiose
core), whereas the canonical GnTI and GnTII enzymes work on
triantennary Man5GlcNAc2 and Man1–6(GlcNAc1-
2Man1–3)Man1–4GlcNAc1–4GlcNAc, respectively.
Methylation linkage analysis of the poly-LacNAc N-glycans
of the TbGT15 null mutant showed a reduction in 6-O-substi-
tuted Gal and 3-O-substituted Gal but an increase in 3,6-O-
substituted Gal. This allows us to augment our model of the
parasites’ complex N-glycans and propose that the Man1–6
arm is normally occupied by predominantly linear poly-Lac-
NAc repeats and the Man1–3 arm by branched as well as
linear poly-LacNAc repeats (Fig. 7).
T. brucei has an unusual dual N-glycosylation mechanism
with two paralogous oligosaccharyltransferases, TbSTT3A and
TbSTT3B, that transfer biantennary Man5GlcNAc2 and trian-
tennary Man9GlcNAc2, respectively, in a site-specific manner
(15, 16). Because of the absence of Golgi -mannosidase II
in the parasite, triantennary structures cannot be processed
to complex N-glycans, rendering biantennary Man5GlcNAc2
transferred by STT3A the only route to paucimannose and
complex structures. Furthermore, the inability of TbGnTI to
act on triantennaryMan5GlcNAc2 (1) also means that bianten-
nary Man5GlcNAc2 transferred bySTT3A is the only possible
route to pseudohybrid N-glycans (i.e. those with only one arm
of the trimannosyl-core modified by GlcNAc	 additional sug-
ars). RNAi knockdown of TbSTT3A showed that cells are via-
ble in culture but not in mice (15). Interestingly, the deletion of
TbGnTI (TbGT11) has no effect on in vitro growth rate, and the
infectivity to mice was indistinguishable from wild type (1).
This suggests that the presence of pseudohybrid N-glycans
with glycan extensions to the 6-arm alone are sufficient to
compensate for the loss of complex N-glycans. Here, the in
vitro and in vivo viability of the TbGnTII null mutant shows
that the reverse is true, in that the presence of hybrid struc-
tures with extensions to the 3-arm alone compensates for the
loss of complex N-glycans. However, despite extensive
attempts, a double knock-out lacking both TbGnTI and
TbGnTII genes could not be generated in our hands, suggest-
ing that extension of one or other of the arms of theN-glycan
trimannosyl-core is essential for the growth and infectivity
of bloodstream form of T. brucei.
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